Invesco Proposes Shareholder Power to Remove Directors Without Cause
IVZ has more than doubled off its 52-week low of $11.6.
Summary
Invesco Ltd. filed additional proxy materials for its annual meeting, proposing a significant governance change to allow shareholders to remove directors with or without cause, alongside other routine proposals.
Key Events · Corporate Governance and Compliance · IVZ
-
Shareholder Meeting Scheduled
The Annual Meeting of Shareholders is scheduled for Thursday, May 21, 2026, to be held virtually.
-
Enhanced Shareholder Rights Proposed
A key proposal recommends amending the company's Bye-Laws to enable shareholders to remove a director with or without cause, increasing board accountability.
-
Routine Governance Proposals
Other proposals include the election of 11 directors, an advisory vote on 2025 executive compensation, and the appointment of PricewaterhouseCoopers LLP as the independent auditor for 2026.
Analysis · IVZ · Finance
This DEFA14A, serving as additional proxy material, highlights key proposals for Invesco's upcoming annual shareholder meeting. The most significant proposal is an amendment to the company's Bye-Laws, which would grant shareholders the ability to remove a director with or without cause. This move enhances shareholder oversight and accountability of the board, aligning with best practices in corporate governance. Other routine proposals include the election of directors, an advisory vote on executive compensation, and the appointment of the independent auditor.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30% of the 1973 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IVZ was trading at $24.14 on NYSE in the Finance sector, with a market capitalization of approximately $10.7B. The 52-week trading range was $11.60 to $29.61. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.